In an autopsy-confirmed case with corticobasal degeneration (CBD), regional flortaucipir binding showed an excellent correlation with 4R tau burden, suggesting higher sensitivity of flortaucipir to 4R tau deposits in CBD, compared with other non-AD tauopathies [78]. The gene discussed is MAPT; the disease is Alzheimer disease.